🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Efficacy and safety of LNP023 in IgAN patients...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-02-07
Trial ID
NCT03373461
The study is an open-label, single arm, multicenter, Phase III study to det...
Status
Recruiting
Location
Childrens Hospital Colorado
Start Date
2025-11-27
Trial ID
NCT06994845
Treatments Being Tested
The study is an open-label, two cohort non-randomized study evaluating the ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-02-20
Trial ID
NCT03832114
Treatments Being Tested
The main purpose of this study was to evaluate the efficacy and safety of i...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2021-12-21
Trial ID
NCT05086744
Treatments Being Tested
The overall purpose of this two-part study is to evaluate the efficacy, saf...
Status
Recruiting
Location
AKDHC Medical Research ServicesLLC
Start Date
2022-08-10
Trial ID
NCT05268289
Treatments Being Tested
This study was a multi-center, randomized, open-label, active comparator-co...
Status
Completed
Location
City Of Hope National Med Center City of Hope Medical Center
Start Date
2021-01-25
Trial ID
NCT04558918
Treatments Being Tested
A study to investigate the impact of iptacopan treatment on the underlying ...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-02-21
Trial ID
NCT06797518
Treatments Being Tested
This was a randomized, open-label, two arm, parallel group, proof-of-concep...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-11-23
Trial ID
NCT04154787
The purpose of this study is to evaluate the long-term safety and tolerabil...
Status
Active Not Recruiting
Location
AZ Kidney Dise and Hypertension Ctr
Start Date
2021-09-20
Trial ID
NCT04557462
Treatments Being Tested
This was an open-label, single dose parallel group study to evaluate the PK...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-11-10
Trial ID
NCT05078580